文献速递心律失常心力衰竭与心肌病瓣膜病与结构性心脏病

疑似心脏结节病患者的CMR表型与长期结局

Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
PubMed 文献 · JAMA Cardiol · 2022-01-01

该队列研究纳入504例组织学确诊结节病并因疑似心脏结节病行CMR的患者,中位随访4.3年,识别出4种基于LVEF和LGE的CMR表型。病理频繁型LGE表型与室性心律失常事件(HR 12.12)和心力衰竭事件(HR 2.49)高风险独立相关。

要点

  • 病理频繁型LGE表型独立预测室性心律失常事件(HR 12.12)和心衰事件(HR 2.49)。
  • 无病理频繁型LGE表型者心律失常风险低,即使存在LGE或LVEF异常。
  • CMR表型可用于优化植入式心律转复除颤器等治疗决策。

核心结论

  • 病理频繁型LGE的CMR表型与结节病患者心律失常和心衰事件高风险相关。
  • CMR表型可用于优化植入式心律转复除颤器等治疗决策。

研究设计与样本

  • 队列研究纳入504例组织学确诊结节病并因疑似心脏结节病行CMR的患者。
  • 中位随访4.3年,数据收集对CMR结果盲法。

主要发现

  • 识别出4种CMR表型:LVEF正常无LGE(57.5%)、LVEF异常无LGE(10.5%)、病理频繁型LGE(20.4%)、病理罕见型LGE(11.5%)。
  • 病理频繁型LGE表型与心律失常事件高风险相关(HR 12.12;95%CI 3.62-40.57;P<.001),独立于LVEF和LVLGE范围。
  • 病理频繁型LGE表型与心衰事件高风险相关(HR 2.49;95%CI 1.19-5.22;P=.02),独立于年龄、肺动脉高压、LVEF、右室射血分数和LVLGE范围。
  • 病理频繁型LGE特征数量越多,心律失常事件风险越高。
  • 无病理频繁型LGE表型者心律失常事件风险低,即使存在LGE或LVEF异常。

临床怎么用

  • 可利用CMR表型(尤其病理频繁型LGE)识别心律失常和心衰高风险结节病患者。
  • CMR表型有助于优化植入式心律转复除颤器等治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: In patients with sarcoidosis with suspected cardiac involvement, late gadolinium enhancement (LGE) on cardiovascular magnetic resonance imaging (CMR) identifies those with an increased risk of adverse outcomes. However, these outcomes are experienced by only a minority of patients with LGE, and identifying this subgroup may improve treatment and outcomes in these patients. OBJECTIVE: To assess whether CMR phenotypes based on left ventricular ejection fraction (LVEF) and LGE in patients with suspected cardiac sarcoidosis (CS) are associated with adverse outcomes during follow-up. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included consecutive patients with histologically proven sarcoidosis who underwent CMR for the evaluation of suspected CS from 2004 to 2020 with a median follow-up of 4.3 years at an academic medical center in Minnesota. Demographic data, medical history, comorbidities, medications, and outcome data were collected blinded to CMR data. EXPOSURES: CMR phenotypes were identified based on LVEF and LGE presence and features. LGE was classified as pathology-frequent or pathology-rare based on the frequency of cardiac damage features on gross pathology assessment of the hearts of patients with CS who had sudden cardiac death or cardiac transplant. MAIN OUTCOMES AND MEASURES: Composite of ventricular arrhythmic events and composite of heart failure events. RESULTS: Among 504 patients (mean [SD] age, 54.1 [12.5] years; 242 [48.0%] female and 262 [52.0%] male; 2 [0.4%] American Indian or Alaska Native, 6 [1.2%] Asian, 90 [17.9%] Black or African American, 399 [79.2%] White, 5 [1.0%] of 2 or more races (including the above-mentioned categories and Native Hawaiian or Other Pacific Islander), and 2 [0.4%] of unknown race; 4 [0.8%] Hispanic or Latino, 498 [98.8%] not Hispanic or Latino, and 2 [0.4%] of unknown ethnicity), 4 distinct CMR phenotypes were identified: normal LVEF and no LGE (n = 290; 57.5%), abnormal LVEF and no LGE (n = 53; 10.5%), pathology-frequent LGE (n = 103; 20.4%), and pathology-rare LGE (n = 58; 11.5%). The phenotype with pathology-frequent LGE was associated with a high risk of arrhythmic events (hazard ratio [HR], 12.12; 95% CI, 3.62-40.57; P < .001) independent of LVEF and extent of left ventricular late gadolinium enhancement (LVLGE). It was also associated with a high risk of heart failure events (HR, 2.49; 95% CI, 1.19-5.22; P = .02) independent of age, pulmonary hypertension, LVEF, right ventricular ejection fraction, and LVLGE extent. Risk of arrhythmic events was greater with an increasing number of pathology-frequent LGE features. The absence of the pathology-frequent LGE phenotype was associated with a low risk of arrhythmic events, even in the presence of LGE or abnormal LVEF. CONCLUSIONS AND RELEVANCE: This cohort study found that a CMR phenotype involving pathology-frequent LGE features was associated with a high risk of arrhythmic and heart failure events in patients with sarcoidosis. The findings indicate that CMR phenotypes could be used to optimize clinical decision-making for treatment options, such as implantable cardioverter-defibrillators.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Athwal PSS, Chhikara S, Ismail MF, et al. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis. JAMA Cardiol. 2022. PMID: 36103165. doi:10.1001/jamacardio.2022.2981

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。